Sangamo Therapeutics, Inc. (SGMO)
0.4273
+0.02
(+4.58%)
USD |
NASDAQ |
Dec 30, 16:00
0.421
-0.01
(-1.47%)
Pre-Market: 08:33
Sangamo Therapeutics Market Cap: 143.78M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 175.87M |
| AIM ImmunoTech, Inc. | 0.9629M |
| Perspective Therapeutics, Inc. | 203.69M |
| Protalix Biotherapeutics, Inc. | 139.93M |
| Armata Pharmaceuticals, Inc. | 226.70M |
Market Cap Related Metrics
| PS Ratio | 3.222 |
| Price to Book Value | 23.03 |
| Price | 0.4273 |
| Earnings Yield | -103.6% |